Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Eletriptan
Drug ID BADD_D00755
Description Eletriptan is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches.
Indications and Usage For the acute treatment of migraine with or without aura in adults.
Marketing Status Prescription
ATC Code N02CC06
DrugBank ID DB00216
KEGG ID D07887
MeSH ID C115647
PubChem ID 77993
TTD Drug ID D02DMQ
NDC Product Code Not Available
Synonyms eletriptan | (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole | UK 166,044 | UK-166044 | UK 166044 | UK-166,044 | Relpax | UK-116044-04 | UK-116,044-04 | eletriptan hydrobromide | (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide | 3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide
Chemical Information
Molecular Formula C22H26N2O2S
CAS Registry Number 143322-58-1
SMILES CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pharyngitis22.07.03.004; 11.01.13.003; 07.05.07.004--
Photophobia17.17.02.006; 06.01.01.0040.001656%
Pneumonia22.07.01.003; 11.01.09.003--Not Available
Pollakiuria20.02.02.007--
Polyarthritis15.01.01.0050.001656%Not Available
Polyuria20.02.03.002--Not Available
Prinzmetal angina24.04.04.015; 02.02.02.019--Not Available
Pruritus23.03.12.001--
Psoriasis23.03.14.002; 10.02.01.036--Not Available
Purpura23.06.01.004; 01.01.04.003; 24.07.06.005--
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Rash maculo-papular23.03.13.004--
Renal pain20.02.03.003--Not Available
Rhabdomyolysis15.05.05.0020.001656%
Rheumatoid arthritis15.01.03.001; 10.04.06.001--Not Available
Rhinitis22.07.03.006; 11.01.13.004--
Salivary hypersecretion07.06.01.009--Not Available
Seizure17.12.03.0010.002485%
Sensory loss17.02.07.007--Not Available
Sepsis11.01.11.0030.001656%
Serotonin syndrome17.05.02.004; 15.05.04.016; 12.03.01.0410.001656%Not Available
Shock24.06.02.002--Not Available
Sinusitis22.07.03.007; 11.01.13.005--
Skin discolouration23.03.03.005--Not Available
Skin disorder23.03.03.007--Not Available
Skin hypertrophy23.01.04.002--Not Available
Sleep disorder19.02.04.0010.001656%Not Available
Somnolence19.02.05.003; 17.02.04.0060.003313%
Speech disorder19.19.02.002; 17.02.08.003; 22.02.05.0340.004141%Not Available
The 7th Page    First    Pre   7 8 9 10    Next   Last    Total 10 Pages